This week the biotech company Denali Therapeutics announced the results of a phase 1 clinical trial of their LRRK2 inhibitor drug called ‘DNL151’. Their findings have interesting implications for the Parkinson’s community.
This award winning documentary was first broadcast in 2019 and features trial participants, including our late co-founder Tom Isaacs, in a cutting-edge drug trial involving complex brain surgery; and it is hoped it will be broadcast again in 2021.
April marks World Parkinson’s Awareness Month to highlight the condition that affects some seven to 10 million people globally. At the centre of this month is World Parkinson’s Day on 11 April.
On 5 May, Cure Parkinson’s supporter Jane Birkin will begin her 5-50-500 TRYathlon, a fundraising challenge she created to mark her 50th birthday!
Can meeting the needs of women living with Parkinson’s unlock new treatments to better manage, slow, stop or even cure Parkinson’s? Re-watch our recent webinar.